High-grade plasma ovarian cancer (the most malignant and common subtype of ovarian cancer) is characterized by TP53 mutations, and cancer genome sequencing studies have found that more than 96% of high-grade plasma ovarian cancers have mutations in the TP53 coding region.57 Here, TP53 is linked to ovarian cancer.